A detailed history of Atomi Financial Group, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Atomi Financial Group, Inc. holds 20,096 shares of VTRS stock, worth $268,683. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,096
Previous 14,293 40.6%
Holding current value
$268,683
Previous $152 Million 53.56%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$10.32 - $12.13 $59,886 - $70,390
5,803 Added 40.6%
20,096 $233 Million
Q2 2024

Jul 26, 2024

SELL
$10.05 - $12.02 $14,090 - $16,852
-1,402 Reduced 8.93%
14,293 $152 Million
Q1 2024

May 07, 2024

SELL
$11.27 - $13.53 $32,840 - $39,426
-2,914 Reduced 15.66%
15,695 $187 Million
Q4 2023

Feb 08, 2024

BUY
$8.77 - $10.85 $163,200 - $201,907
18,609 New
18,609 $202 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $16.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Atomi Financial Group, Inc. Portfolio

Follow Atomi Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atomi Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atomi Financial Group, Inc. with notifications on news.